Key Market Indicators
Korean beta blocking medicine sales are forecast to reach $112.63 million by 2026. In 2021, sales in the country were $121.33 million, down 0.9% from the previous year. Since 2013, Korean sales have grown at an average rate of 2.6% annually. In 2021, the country came in sixth place in the rankings, with Spain in the top spot at $121.33 million. Italy, Canada and Australia followed in second, third and fourth place respectively.
